An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals.
暂无分享,去创建一个
[1] P. Conti,et al. Synthesis of a novel bifunctional chelator AmBaSar based on sarcophagine for peptide conjugation and (64)Cu radiolabelling. , 2009, Dalton transactions.
[2] T. Nayak,et al. Radioimmunoimaging with longer-lived positron-emitting radionuclides: potentials and challenges. , 2009, Bioconjugate chemistry.
[3] S. Achilefu,et al. (64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity. , 2009, Nuclear medicine and biology.
[4] Samantha V. Sublett,et al. In vitro and in vivo analysis of [(64)Cu-NO2A-8-Aoc-BBN(7-14)NH(2)]: a site-directed radiopharmaceutical for positron-emission tomography imaging of T-47D human breast cancer tumors. , 2009, Nuclear medicine and biology.
[5] J. Steinbach,et al. Hexadentate bispidine derivatives as versatile bifunctional chelate agents for copper(II) radioisotopes. , 2009, Bioconjugate chemistry.
[6] Anna M. Wu,et al. Antibodies and Antimatter: The Resurgence of Immuno-PET , 2008, Journal of Nuclear Medicine.
[7] M. Gleave,et al. Evaluation of novel bifunctional chelates for the development of Cu-64-based radiopharmaceuticals. , 2008, Nuclear medicine and biology.
[8] Shuang Liu. Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides. , 2008, Advanced drug delivery reviews.
[9] Katsunori Tanaka,et al. PET (positron emission tomography) imaging of biomolecules using metal-DOTA complexes: a new collaborative challenge by chemists, biologists, and physicians for future diagnostics and exploration of in vivo dynamics. , 2008, Organic & biomolecular chemistry.
[10] L. Spiccia,et al. Synthesis, Copper(II) Complexation, (64)Cu-Labeling, and Bioconjugation of a New Bis(2-pyridylmethyl) Derivative of 1,4,7-Triazacyclononane. , 2008, Bioconjugate chemistry.
[11] Smith Sv. Sarar technology for the application of Copper-64 in biology and materials science. , 2008 .
[12] S. Treves,et al. Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugates , 2007, Proceedings of the National Academy of Sciences.
[13] C. Anderson,et al. Copper chelation chemistry and its role in copper radiopharmaceuticals. , 2007, Current pharmaceutical design.
[14] N. Di Bartolo,et al. New 64Cu PET imaging agents for personalised medicine and drug development using the hexa-aza cage, SarAr. , 2006, Organic & biomolecular chemistry.
[15] Suzanne V. Smith. Molecular imaging with copper-64. , 2004, Journal of inorganic biochemistry.
[16] Peter S. Conti,et al. Pegylated Arg-Gly-Asp Peptide: 64Cu Labeling and PET Imaging of Brain Tumor αvβ3-Integrin Expression , 2004 .
[17] Ryan Park,et al. MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide. , 2004, Bioconjugate chemistry.
[18] A. Sargeson,et al. Synthesis of a new cage ligand, SarAr, and its complexation with selected transition metal ions for potential use in radioimaging , 2001 .
[19] J. Lewis,et al. Copper radionuclides and radiopharmaceuticals in nuclear medicine. , 1996, Nuclear medicine and biology.
[20] A. Beatty,et al. Synthesis and Characterization of Cobalt-Cage Complexes with Pendant Phenol Groups. , 1996, Inorganic chemistry.